Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released May 8, 2025, after the close
10-Q filed May 8, 2025, 38 days after period end · 0001410578-25-001111
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $695.00K | $156.00K | $967.00K | $174.00K |
| Net Income | -$53.80M | -$32.81M | — | — |
| EPS Diluted |
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
| -$0.81 |
| -$0.56 |
| -$0.62 |
| -$0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.